Cardinal Health, Inc.
CAHHealthcareNASDAQMedical Distribution · Last scanned Oct 26, 2026
Scan Results
Daily timeframePart of the healthcare sector, Cardinal Health, Inc. (CAH) is listed under Medical Distribution. At a $57.79B market cap, Cardinal Health, Inc. ranks as a large-cap company within healthcare. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
Market Cap
$57.79B
Beta
0.50
P/E (TTM)
34.52
P/E (Fwd)
17.75
EPS (TTM)
$7.23
EPS (Fwd)
$14.06
ROE
—
ROA
3.7%
Cash
$4.86B
Total Debt
$10.00B
Free CF
$4.75B
52W Change
52.4%
Annual Financials
Cash vs Debt
Where CAH stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, CAH finished 14.56% above its 150-day moving average ($220.54) and 15.27% above its 200-day moving average ($219.19). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CAH overbought or oversold?
At the October 20, 2026 close, CAH's RSI(14) was 83.4, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $4.86B in cash, though total debt stands at $10.00B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $4.75B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROA of 3.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $204.98B (2023) to $254.25B (2026), reflecting a 24% increase over the period.
The relatively low beta of 0.50 suggests CAH is a less volatile holding compared to the broader index. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Cardinal Health, Inc.'s trajectory.